120 filings
Page 2 of 6
8-K
ycp2wr
6 Nov 23
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:10am
8-K
4hx8 701q0p6rz
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
hjmvbl
11 Aug 23
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:22am
8-K
ked6p
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
abgpwypnua3
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
jtanwayya23
29 Jun 23
Prospectus supplement for primary offering
6:02am
8-K
kalv nq8qrc0
27 Jun 23
Regulation FD Disclosure
7:11am
8-K
su00ddedgt3
16 May 23
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
79q2l7s du9
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am
ARS
k9pnc7c1
4 Apr 23
Annual report to shareholders
5:19pm
DEFA14A
95nvy vydy76d
4 Apr 23
Additional proxy soliciting materials
5:18pm
S-8
anqkyksn1 xe1
9 Mar 23
Registration of securities for employees
4:01pm
8-K
5hwgkcw
9 Mar 23
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
7:46am
8-K
s1kfhe f85s7ap4n
19 Dec 22
Black Diamond Therapeutics Announces Changes to Board of Directors
8:20am
8-K
7gacjv cc
12 Dec 22
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
8:04am